# The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study

> **NCT03255174** · PHASE3 · COMPLETED · sponsor: **Ethicon, Inc.** · enrollment: 35 (actual)

## Conditions studied

- Controlling Mild to Moderate Bleeding During Surgery

## Interventions

- **BIOLOGICAL:** EVARREST® Fibrin Sealant Patch

## Key facts

- **NCT ID:** NCT03255174
- **Lead sponsor:** Ethicon, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-20
- **Primary completion:** 2025-01-22
- **Final completion:** 2025-02-14
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03255174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03255174, "The EVARREST® Pediatric Mild or Moderate Liver and Soft Tissue Bleeding Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03255174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*